We recently compiled a list of the 12 Cheap Pot Stocks to Buy According to Hedge Funds. Aurora Cannabis Inc. stands fourth on our list. Aurora Cannabis Inc. (NASDAQ:ACB), a prominent Canadian medical cannabis company, is strengthening its global footprint by focusing on international markets, particularly in Europe and Australia. The company has shifted away from recreational cannabis, positioning itself as a leader in the medical segment with strong fiscal results, reporting a 93% year-over-year increase in global medical cannabis revenue, which has now surpassed its domestic Canadian sales. Australia has become a key growth market where the company ranks as the second-largest supplier, while Germany’s progressive cannabis laws offer further expansion opportunities. Aurora Cannabis Inc. (NASDAQ:ACB)’s growing international presence and improving fundamentals have placed it among cheap pot stocks to buy, especially for investors seeking value in the medical cannabis space. Its international growth is underpinned by a debt-free cannabis business, positive adjusted EBITDA, and a renewed focus on profitability, marking a notable turnaround. The company continues to engage shareholders, with its 2025 Annual General and Special Meeting scheduled for August 8. Aurora Cannabis Inc. (ACB) Becomes Medical Market Powerhouse with 93% Sales Jump A laboratory filled with medical cannabis research equipment and supplies. Beyond financials, the business remains committed to social responsibility through initiatives like “Strains for Heroes,” which develops medical cannabis products for veterans in collaboration with the community. Five percent of net profits from these products are donated to veteran-focused organizations, demonstrating the company’s commitment to both innovation and impact. While we acknowledge the potential of ACB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. View Comments
Aurora Cannabis Inc. (ACB) Becomes Medical Market Powerhouse with 93% Sales Jump
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...